RIGL Rigel Pharmaceuticals
- 0.984
- -0.206-17.34%
Rigel Pharmaceuticals News
Rigel Pharmaceuticals | 8-K: Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
Rigel Pharmaceuticals | 8-K: Current report
Rigel Pharmaceuticals | DEFA14A: Others
Rigel Pharmaceuticals | DEF 14A: Definitive information statements
Rigel Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Rigel Pharmaceuticals | 8-K: Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Rigel Pharmaceuticals | 8-K: Current report
Rigel Pharmaceuticals | 8-K: Current report
Rigel Pharmaceuticals | 8-K: Current report
Rigel Pharmaceuticals | 8-K: Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update
Rigel Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Rigel Pharmaceuticals | 8-K: Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update
Rigel Pharmaceuticals | 8-K: Current report
Rigel Pharmaceuticals | DEFR14A: Definitive proxy statement in connection with contested solicitations
Rigel Pharmaceuticals | 8-K: Rigel Reports First Quarter 2023 Financial Results and Provides Business Update
Rigel Pharmaceuticals | DEFA14A: Others
Rigel Pharmaceuticals | DEF 14A: Definitive proxy statements
Rigel Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Rigel Pharmaceuticals | 8-K: Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Rigel Pharmaceuticals | 8-K: Current report
Analysis
Price Target
No Data
